Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure

Western Journal of Medicine

Volumn 167, Issue 1, 1997, Pages 44-47

  Bertken, Richard D ^a,b   Cooper, Viraf R ^a  

^a University Medical Center Fresno   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; HYDROCORTISONE; LUTEINIZING HORMONE; PREDNISONE;

ADULT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYDROCEPHALUS; HYPOPITUITARISM; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SELLA TURCICA TUMOR; WEGENER GRANULOMATOSIS;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DAPSONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; HYDROCEPHALUS; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; SELLA TURCICA; WEGENER GRANULOMATOSIS;

EID: 0030800167     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Roberts GA, Eren E, Sinclair H, Pelling M, Burns A, Bradford R, et al. Two cases of Wegener's granulomatosis involving the pituitary. Clin Endocrinol 1995; 42:323-328
2. Leavitt RY, Fauci AS. Less common manifestations and presentations of Wegener's granulomatosis. Curr Opin Rheumatol 1992; 4:16-22
3. Duna GF, Galperin C, Huffman GS. Wegener's granulomatosis. Rheum Dis Clin N Am 1995; 21:949-986
4. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995; 123:925-932
5. Rao JK, Allen MB, Feussner JR, Weinberger M. A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 347:926-931
6. Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin N Am 1995; 21:987-1011
7. Anderson G, Coles ET, Crane M, Douglas CA, Gibbs AR, Geddes DM, et al. Wegener's granuloma. A series of 2654 British cases seen between 1975 and 1985. Q J Med 1992; 83:427-438
8. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85
9. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Huffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthr Rheum 1993; 36:365-371
10. Israel HL. Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988; 148:2293-2295
11. deGroot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nolle B, et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthr Rheum 1996; 39:2052-2061
12. Stegeman CA, Cohen TJW, de Jong PE, Kallengerg CG. Trimethoprim-sulfamethoxazole for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 33:16-20
13. Robert DE, Curd JG. Sulfonamides as antiinflammatory agents in the treatment of Wegener's granulomatosis. Arthr Rheum 1990; 33:1590-1593
14. Drosos AA, Sakkas LI, Siamopoulos KC, Moutsopoulos HM. Pulse cyclophosphamide therapy in Wegener's granulomatosis; a pilot study. J Intern Med 1992: 232:279-282
15. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegner's granulomatosis. Arthr Rheum 1994; 37:919-924